[
  {
    "ts": null,
    "headline": "Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy",
    "summary": "Investing.com -- Goldman Sachs has launched coverage of the Life Sciences Tools sector with a selective stance, arguing that the group should ultimately “return to their historic market growth rate of ~5%,” but only as certain end markets recover faster than others.",
    "url": "https://finnhub.io/api/news?id=816aafe60d042584179112cfaf041dd52bb6547997b0a27c52f96123b6214bc8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765286218,
      "headline": "Goldman Sachs starts Life Sciences Tools coverage, rates these 3 stocks at Buy",
      "id": 137740198,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RVTY",
      "source": "Yahoo",
      "summary": "Investing.com -- Goldman Sachs has launched coverage of the Life Sciences Tools sector with a selective stance, arguing that the group should ultimately “return to their historic market growth rate of ~5%,” but only as certain end markets recover faster than others.",
      "url": "https://finnhub.io/api/news?id=816aafe60d042584179112cfaf041dd52bb6547997b0a27c52f96123b6214bc8"
    }
  }
]